Safety and immune response study of VAX-A1 vaccine in healthy young adults
Part of Infections clinical trials.
This study tests a new vaccine called VAX-A1 in healthy people aged 18–40 to see if it's safe and if it helps the body build protection against Group A Streptococcus (a bacteria that can cause serious infections). You'll receive two vaccine doses and have blood tests and heart monitoring over 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old
- You are in overall good health with no serious medical conditions
- You have not had recent Group A Streptococcus infection or related complications
- You do not have an autoimmune disease, HIV, hepatitis B or C, or a bleeding disorder
- You can attend follow-up visits for 6 months after your second vaccine dose
- You can use a smartphone, tablet, or computer to complete a daily diary during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaccine designed to protect against Group A Strep bacteria. It will check how safe the vaccine is and how well it boosts your immune system. Healthy young adults between 18 and 25 years old may be eligible.
This study tests whether a new antibody treatment can safely stop strep throat infections. Healthy adults aged 18-40 will receive the antibody and then be exposed to the strep bacteria in a controlled setting to see if it protects them.
This study tests a new vaccine called StreptInCor that may help prevent rheumatic fever (a condition caused by strep infections that can damage the heart). It is an early trial to check if the vaccine is safe and produces a good immune response in healthy adults.
This early-phase study tests whether a new vaccine called V118E is safe and well-tolerated in healthy people. It is for adults who are in good health and have not recently had a pneumococcal infection.
This trial tests two new experimental vaccines to see if they are safe and how the body responds to them. It is only for healthy adults, so if you are generally well, you might be able to take part.
This study tests a new medicine in healthy volunteers to see how safe it is and how the body handles it. You will need to have had certain vaccines (meningitis and pneumonia) before joining, and you must be in generally good health.
Hear when a new Group A Streptococcal Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.